Literature DB >> 19148804

Multistep human hepatocarcinogenesis: correlation of imaging with pathology.

Masatoshi Kudo1.   

Abstract

Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide. The majority of HCCs develop in cirrhotic livers, and the early detection and characterization of this entity is very important. Pathologically, human HCC develops in a multistep fashion in the following sequence: from low-grade dysplastic nodule (LGDN), to high-grade dysplastic nodule (HGDN), early HCC, well-differentiated HCC, nodule-in-nodule HCC, and, finally, to moderately differentiated HCC. Differentiation between early HCC and DN is the most important issue in the clinical setting. CT during hepatic angiography (CTHA) and CT during arterial portography (CTAP) are the most sensitive tools in the differentiation of premalignant/borderline lesions (LGDN and HGDN) and early HCC. Recent progress in imaging modality, especially Sonazoidenhanced US and Gd-EOB-DTPA MRI, is starting to play a very important role in the imaging of multistep hepatocarcinogenesis, resulting in changing the therapeutic strategy of these nodular lesions associated with liver cirrhosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19148804     DOI: 10.1007/s00535-008-2274-6

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  52 in total

1.  Hepatocellular carcinoma transforming from dysplastic nodule with background of non-B non-C chronic persistent hepatitis.

Authors:  S R Kim; Y Hayashi; M Kudo; T Matsuoka; S Imoto; K B Song; Y Maekawa
Journal:  J Hepatol       Date:  2000-11       Impact factor: 25.083

Review 2.  Pitfalls in the imaging diagnosis of hepatocellular nodules in the cirrhotic and noncirrhotic liver.

Authors:  Kengo Yoshimitsu; Hiroyuki Irie; Hitoshi Aibe; Tsuyoshi Tajima; Akihiro Nishie; Yoshiki Asayama; Kunishige Matake; Tomohiro Nakayamka; Daisuke Kakihara; Hiroshi Honda
Journal:  Intervirology       Date:  2004       Impact factor: 1.763

Review 3.  Multidetector row CT and MR imaging in diagnosing hepatocellular carcinoma.

Authors:  Takamichi Murakami; Masatoshi Hori; Tonsok Kim; Shuji Kawata; Hisashi Abe; Hironobe Nakamura
Journal:  Intervirology       Date:  2004       Impact factor: 1.763

Review 4.  Early detection and curative treatment of early-stage hepatocellular carcinoma.

Authors:  Masatoshi Kudo
Journal:  Clin Gastroenterol Hepatol       Date:  2005-10       Impact factor: 11.382

5.  Validation of a new prognostic staging system for hepatocellular carcinoma: the JIS score compared with the CLIP score.

Authors:  Masatoshi Kudo; Hobyung Chung; Seiji Haji; Yukio Osaki; Hiroko Oka; Toshihito Seki; Hiroshi Kasugai; Yo Sasaki; Takashi Matsunaga
Journal:  Hepatology       Date:  2004-12       Impact factor: 17.425

6.  Hepatocellular carcinoma with nodule-in-nodule appearance: demonstration by contrast-enhanced coded phase inversion harmonic imaging.

Authors:  Rong Qin Zheng; Pei Zhou; Masatoshi Kudo
Journal:  Intervirology       Date:  2004       Impact factor: 1.763

Review 7.  Atypical large well-differentiated hepatocellular carcinoma with benign nature: a new clinical entity.

Authors:  Masatoshi Kudo
Journal:  Intervirology       Date:  2004       Impact factor: 1.763

8.  Characteristic difference of hepatocellular carcinoma between hepatitis B- and C- viral infection in Japan.

Authors:  Y Shiratori; S Shiina; M Imamura; N Kato; F Kanai; T Okudaira; T Teratani; G Tohgo; N Toda; M Ohashi
Journal:  Hepatology       Date:  1995-10       Impact factor: 17.425

9.  Early hepatocellular carcinoma: appearance at CT during arterial portography and CT arteriography with pathologic correlation.

Authors:  K Takayasu; Y Muramatsu; H Furukawa; F Wakao; N Moriyama; T Takayama; S Yamasaki; M Sakamoto; S Hirohashi
Journal:  Radiology       Date:  1995-01       Impact factor: 11.105

10.  The morphologic transition in hepatocellular carcinoma. A comparison of the individual histologic features disclosed by ultrasound-guided fine-needle biopsy with those of autopsy.

Authors:  S Sugihara; O Nakashima; M Kojiro; Y Majima; M Tanaka; K Tanikawa
Journal:  Cancer       Date:  1992-09-15       Impact factor: 6.860

View more
  75 in total

1.  Detection of focal liver lesions in cirrhotic liver using contrast-enhanced ultrasound.

Authors:  Grace Lai-Hung Wong; Hui-Xiong Xu; Xiao-Yan Xie
Journal:  World J Radiol       Date:  2009-12-31

2.  Early hepatocellular carcinoma: definition and diagnosis.

Authors:  M Kudo
Journal:  Liver Cancer       Date:  2013-04       Impact factor: 11.740

3.  Incidence for progression of hypervascular HCC in hypovascular hepatic nodules showing hyperintensity on gadoxetic acid-enhanced hepatobiliary phase in patients with chronic liver diseases.

Authors:  Megumi Matsuda; Takaharu Tsuda; Shinji Yoshioka; Shigetoshi Murata; Hiroaki Tanaka; Masashi Hirooka; Yoichi Hiasa; Teruhito Mochizuki
Journal:  Jpn J Radiol       Date:  2014-05-24       Impact factor: 2.374

Review 4.  Focal liver lesions detection and characterization: The advantages of gadoxetic acid-enhanced liver MRI.

Authors:  Stefano Palmucci
Journal:  World J Hepatol       Date:  2014-07-27

5.  A sub-centimeter HCC with bright loop appearance diagnosed by contrast-enhanced ultrasonography.

Authors:  Shuichi Sato; Tatsuya Miyake; Asako Fukuma; Eri Nitta; Noritsugu Yamashita; Takuya Hanaoka; Junichi Ishine; Hiroshi Tobita; Shuji Akagi; Yuji Amano; Yoshikazu Kinoshita
Journal:  J Med Ultrason (2001)       Date:  2010-11-27       Impact factor: 1.314

6.  Contribution of the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI to Dynamic MRI in the detection of hypovascular small (≤ 2 cm) HCC in cirrhosis.

Authors:  Rita Golfieri; Matteo Renzulli; Vincenzo Lucidi; Beniamino Corcioni; Franco Trevisani; Luigi Bolondi
Journal:  Eur Radiol       Date:  2011-02-05       Impact factor: 5.315

Review 7.  Magnetic resonance imaging of the cirrhotic liver: An update.

Authors:  Agnes Watanabe; Miguel Ramalho; Mamdoh AlObaidy; Hye Jin Kim; Fernanda G Velloni; Richard C Semelka
Journal:  World J Hepatol       Date:  2015-03-27

8.  Time to update radiological criteria for non-invasive diagnosis of hepatocellular carcinoma.

Authors:  Sanjay Saini; Daniel S Pratt
Journal:  Hepatol Int       Date:  2014-11-02       Impact factor: 6.047

9.  Dynamic contrast-enhanced MRI perfusion quantification in hepatocellular carcinoma: comparison of gadoxetate disodium and gadobenate dimeglumine.

Authors:  Daniel Stocker; Stefanie Hectors; Octavia Bane; Naik Vietti-Violi; Daniela Said; Paul Kennedy; Jordan Cuevas; Guilherme M Cunha; Claude B Sirlin; Kathryn J Fowler; Sara Lewis; Bachir Taouli
Journal:  Eur Radiol       Date:  2021-05-27       Impact factor: 5.315

10.  Evolution of indeterminate hepatocellular nodules at Gd-EOB-DPTA-enhanced MRI in cirrhotic patients.

Authors:  Massimo Galia; Francesco Agnello; Gianvincenzo Sparacia; Domenica Matranga; Domenico Albano; Massimo Midiri; Roberto Lagalla
Journal:  Radiol Med       Date:  2018-03-15       Impact factor: 3.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.